Canada bans imports of drugs from three Indian facilitiesBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g6153 (Published 10 October 2014) Cite this as: BMJ 2014;349:g6153
- Cheryl Travasso
Canada’s federal health department, Health Canada, has stopped importing drugs from three Indian facilities because of problems with data collection and doubts about the quality and safety of some products and active ingredients used at the sites.
Concerns about products from Apotex Pharmachem India, Apotex Research, and IPCA Laboratories were first …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial